TJP2 and prostate cancer: Nevertheless, this study demonstrates for the first time that Akt1 suppression in endothelial cells will promote prostate cancer metastasis involving β-catenin-mediated suppression of tight-junction proteins such as claudin-5, ZO-1 and ZO-2.